The short version of carcinogenicity fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Solubility | Soluble in dimethyl sulfoxide and some organic solvents; practically insoluble in water | Solvent choice affects laboratory handling |
| Typical storage | -20 °C, desiccated, protected from light | Common condition for research samples |
| Analytical method | Liquid chromatography–tandem mass spectrometry (LC-MS/MS) | Used for identification and quantification in biological or product samples |
| Common synonyms | GW501516, GW-501516, GSK-516, Endurobol | Names found in research and anti-doping literature |
| Regulatory status | Unapproved therapeutic; prohibited in competitive sport | Status can vary by country and context |
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
WebElements – Selenium NIH – Selenium Fact Sheet for Consumers Assay – Supra-Regional Assay Service ATSDR – Toxicological Profile for Selenium Elementymology & Elements Multidict – Selenium page by Peter van der Krogt
The α1-adrenergic receptor antagonist prazosin is used off-label to treat insomnia, nightmares, and poor sleep quality in people with post-traumatic stress disorder (PTSD). It is clinically effective for this purpose. However, the drug is also an antihypertensive agent and can lower blood pressure, thereby producing side effects like dizziness and orthostatic hypotension. Certain non-selective hypnotics such as trazodone and tricyclic antidepressants (TCAs) like amitriptyline and trimipramine are also α1-adrenergic receptor antagonists. The combination of prazosin and the centrally-penetrant beta blocker (β-adrenergic receptor antagonist) timolol has been found to be synergistic in producing sedative and hypnotic effects in animals. Conversely, timolol alone produced no such effects. Centrally active beta blockers like propranolol and metoprolol on their own are not effective or clinically used as hypnotics and have actually been associated with insomnia as a side effect. Certain beta blockers like labetalol and carvedilol also block the α1-adrenergic receptor to varying extents and have been associated with somnolence as a side effect similarly. However, these two beta blockers have also been associated with insomnia as with selective beta blockers.
=== Gene cluster === The study of the genetic cluster encoding the biosynthesis of teicoplanin identified 49 putative open reading frames (ORFs) involved in the compound's biosynthesis, export, resistance, and regulation. Thirty-five of these ORFs are similar to those found in other glycopeptide gene clusters. The function of each of these genes is described by Li and co-workers. A summary of the gene layout and purpose is shown below. Gene layout. The genes are numbered. The letters L and R designate transcriptional direction. The presence of the * symbol means a gene is found after NRPs, which are represented by A, B, C, and D. Based on the figure from: Li, T-L.; Huang, F.; Haydock, S. F.; Mironenko, T.; Leadlay, P. F.; Spencer, J. B. Chemistry & Biology. 2004, 11, p. 109. [11-L] [10-L] [9-R] [8-R] [7-R] [6-R] [5-R] [4-L][3-L] [2-L] [1-R] [A-R] [B-R] [C-R] [D-R] [1*-R] [2*-R] [3*-R] [4*-R] [5*-R] [6*-R] [7*-R] [8*-R] [9*-R] [10*-R] [11*-R] [12*-R] [13*-R] [14*-R] [15*-R] [16*-R] [17*-R] [18*-R] [19*-R] [20*-R] [21*-R] [22*-R] [23*-R] [24*-R] [25*-L] [26*-L] [27*-R] [28*-R] [29*-R] [30*-R][31*-R] [32*-L] [33*-L] [34*-R]
Clomipramine may interact with monoamine oxidase inhibitors (MAOIs) such as isocarboxazid, moclobemide, phenelzine, selegiline, and tranylcypromine. These combinations are generally avoided due to the severe risk of adverse reactions. The medication also interacts with antiarrhythmic agents because tricyclic antidepressants (TCAs) can significantly alter cardiac conduction. A specific pharmacokinetic interaction exists with quinidine; since clomipramine is metabolized by the enzyme CYP2D6 in vivo, quinidine can impede this process and raise drug levels. Similarly, diuretics pose a secondary risk; by potentially inducing hypokalaemia (low blood potassium), they increase the likelihood of QT interval prolongation and the life-threatening heart rhythm known as torsades de pointes. Furthermore, clomipramine reacts with selective serotonin reuptake inhibitors (SSRIs) through two distinct mechanisms. First, there is a risk of additive serotonergic effects that can lead to serotonin syndrome. Second, a pharmacokinetic interaction occurs with SSRIs that inhibit CYP2D6—specifically fluoxetine and paroxetine—which can lead to toxic levels of clomipramine in the bloodstream. This risk of serotonin toxicity or serotonin syndrome extends to other serotonergic agents, including triptans, other tricyclic antidepressants, and tramadol. Fluvoxamine increases the serotonergic effects of clomipramine and, likewise, clomipramine increases fluvoxamine levels.
Sources: en.wikipedia.org
BioShock was bundled with The Elder Scrolls IV: Oblivion as a double pack on PC and Xbox 360 on July 7, 2009. A port to OS X systems was made by Feral Interactive and released in October 2009. In early 2008, IG Fun secured the rights to develop and publish a mobile phone version of BioShock. This version was developed as a top-down, two-dimensional platformer that attempted to recreate most of the plot and game elements of the original title; IG Fun worked with Irrational to determine the critical story elements they wanted to keep in the game. IG Fun recognized they would not be able to include the full storyline within a single mobile title, and so planned to split the title into three "episodes". Only the first episode was released. Another mobile port was developed by Tridev, known as BioShock 3D, released in 2010. Several parts of the game were reduced to single image graphics and the main gameplay engine had to use low-resolution and low-polygon models due to the limitations of mobile phones at the time of its release. A port to iOS devices done by the 2K China studio was released on August 27, 2014. The iOS version is content complete and functionally equivalent to the original Xbox 360 and Windows version, featuring either the use of touch-screen virtual gamepad controls or the use of a Bluetooth-enabled controller, and with a graphics engine optimized for iOS devices.
Morgan State University (MSU) is a historically black college in Baltimore, Maryland. It was founded in 1867 as the Centenary Biblical Institute, a Methodist Episcopal seminary, to train young men in the ministry. At the time of his death, Thomas Kelso, co-founder and president of the board of directors, endowed the Male Free School and Colored Institute through a legacy of his estate. It later broadened its mission to educate both men and women as teachers. The school was renamed as Morgan College in 1890 in honor of the Reverend Lyttleton Morgan, the first chairman of its board of trustees, who donated land to the college. In 1895, the institution awarded its first baccalaureate degree to George W. F. McMechen, after whom the building of the school of business and management is named today. McMechen later earned a law degree from Yale University and, after establishing his career, became one of Morgan's main financial supporters. John O. Spencer became the fifth president of Morgan College in 1902, and served in that position until 1937. In 1902, Morgan's assets were a little over $100,000 in grounds, equipment and endowments, including its branch schools at the time; the then Princess Anne Academy and the Virginia Collegiate and Industrial Institute. During his tenure as president, the university saw major expansions across the campus. By 1937, the school's assets were more than $1,000,000 and its enrollment had grown from 150 to 487.
== Education and early career == Barran went to Godolphin and Latymer School. She moved to the University of Manchester to study chemistry, graduating in 1994. She joined the University of Sussex for her graduate studies, working with Harry Kroto and Tony Stace.
Sources: en.wikipedia.org
β-Carotene (beta-carotene) is an organic, strongly colored red-orange pigment abundant in fungi, plants, and fruits. It is a member of the carotenes, which are terpenoids (isoprenoids), synthesized biochemically from eight isoprene units and thus having 40 carbons. Dietary β-carotene is a provitamin compound, converting in the body to retinol (vitamin A). In foods, it has rich content in carrots, pumpkin, spinach, and sweet potato. It is used as a dietary supplement and may be prescribed to treat erythropoietic protoporphyria, an inherited condition of sunlight sensitivity. β-carotene is the most common carotenoid in plants. When used as a food coloring, it has the E number E160a. The structure was deduced in 1930. Isolation of β-carotene from fruits abundant in carotenoids is commonly done using column chromatography. It is industrially extracted from richer sources such as the algae Dunaliella salina. The separation of β-carotene from the mixture of other carotenoids is based on the polarity of a compound. β-Carotene is a non-polar compound, so it is separated with a non-polar solvent such as hexane. Being highly conjugated, it is deeply colored, and as a hydrocarbon lacking functional groups, it is lipophilic.
=== Canada === During his visit to North America in August 1941, Howard Florey approached the Connaught Laboratories at the University of Toronto, where he met with the director, R. D. Defries, and Ronald Hare. Florey was rebuffed; Defries argued that the laboratories did not have the space, and he expressed his belief that constructing facilities to culture penicillin would be a waste as it would soon be synthesised. The results of clinical trials caused a change of heart, and in August 1943 the Canadian government asked the Connaught Laboratories to initiate mass production of penicillin. The Spadina Building was purchased by the University of Toronto for the purpose, and refurbished at a cost of Canadian $1.2 million (equivalent to Canadian $22 million in 2025), split equally between the university and the government. Penicillin was initially cultured in 200,000 bottles occupying 740 square metres (8,000 sq ft) of air-conditioned laboratory space. Production was switched to the deep submergence method in November 1945.
On 26 September 1983, Stanislav Petrov, a lieutenant colonel in the Soviet Air Defense Forces, was the officer on duty at the Serpukhov-15 bunker near Moscow which housed the command center of the Soviet early warning satellites, code-named Oko. Petrov's responsibilities included observing the satellite early-warning network and notifying his superiors of any impending nuclear missile attack against the Soviet Union. If notification was received from the early-warning systems that inbound missiles had been detected, the Soviet Union's strategy was an immediate and compulsory nuclear counter-attack against the United States (launch on warning), specified in the doctrine of mutual assured destruction. Shortly after midnight, the bunker's computers reported that one intercontinental ballistic missile was heading toward the Soviet Union from the United States. Petrov considered the detection a computer error, since a first-strike nuclear attack by the United States was likely to involve hundreds of simultaneous missile launches in order to disable any Soviet means of a counterattack. Furthermore, the satellite system's reliability had been questioned in the past. Petrov dismissed the warning as a false alarm, though accounts of the event differ as to whether he notified his superiors or not after he concluded that the computer detections were false and that no missile had been launched. Petrov's suspicion that the warning system was malfunctioning was confirmed when no missile arrived.
Sources: en.wikipedia.org
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.
No. It is not an anabolic-androgenic steroid; it is a synthetic PPARδ agonist. Because it is banned in sport, it is sometimes grouped with doping agents even though its chemical class differs from steroids.
Human data are limited and development was discontinued, so major effects and long-term risks are not well characterized. Some early studies examined metabolic markers, but they do not provide a basis for unsupervised use.
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.